Markets
Dyne Therapeutics CEO John Cox Sells $49,179 in Stock: What Insider Activity Signals for DYNE
Dyne Therapeutics CEO John Cox has offloaded $49,179 worth of DYNE shares, triggering fresh scrutiny of insider sentiment at the clinical-stage biotech. Here's what the transaction reveals — and what traders should watch at current price levels.